Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiration, Artificial | 9 | 2023 | 84 | 2.530 |
Why?
|
| Respiratory Insufficiency | 11 | 2023 | 46 | 1.930 |
Why?
|
| Ventilator Weaning | 5 | 2023 | 21 | 1.250 |
Why?
|
| Oxygen Inhalation Therapy | 5 | 2022 | 16 | 1.050 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2017 | 21 | 1.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2020 | 42 | 0.860 |
Why?
|
| Prone Position | 11 | 2023 | 25 | 0.760 |
Why?
|
| Oxygen | 4 | 2023 | 56 | 0.720 |
Why?
|
| Positive-Pressure Respiration | 1 | 2021 | 7 | 0.710 |
Why?
|
| Intensive Care Units | 2 | 2022 | 234 | 0.660 |
Why?
|
| Hospitals | 1 | 2020 | 157 | 0.610 |
Why?
|
| Hypoxia | 3 | 2021 | 30 | 0.600 |
Why?
|
| Wakefulness | 10 | 2023 | 68 | 0.570 |
Why?
|
| Humans | 34 | 2023 | 23187 | 0.540 |
Why?
|
| Epoprostenol | 1 | 2017 | 4 | 0.530 |
Why?
|
| Metered Dose Inhalers | 2 | 2017 | 4 | 0.530 |
Why?
|
| Tidal Volume | 2 | 2017 | 9 | 0.530 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 25 | 0.520 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 42 | 0.510 |
Why?
|
| Albuterol | 1 | 2017 | 14 | 0.510 |
Why?
|
| Bronchodilator Agents | 1 | 2017 | 11 | 0.510 |
Why?
|
| Patient Satisfaction | 2 | 2017 | 257 | 0.460 |
Why?
|
| Quality of Life | 3 | 2018 | 564 | 0.430 |
Why?
|
| Respiration | 2 | 2017 | 27 | 0.430 |
Why?
|
| Aerosols | 3 | 2020 | 14 | 0.430 |
Why?
|
| Exercise | 1 | 2017 | 404 | 0.410 |
Why?
|
| Helium | 1 | 2013 | 1 | 0.400 |
Why?
|
| Lung | 4 | 2023 | 139 | 0.400 |
Why?
|
| Carbon Dioxide | 1 | 2013 | 17 | 0.390 |
Why?
|
| Patient Positioning | 6 | 2023 | 34 | 0.390 |
Why?
|
| Intubation, Intratracheal | 4 | 2023 | 82 | 0.380 |
Why?
|
| Ventilators, Mechanical | 3 | 2023 | 19 | 0.380 |
Why?
|
| Respiratory Muscles | 2 | 2023 | 13 | 0.370 |
Why?
|
| Airway Extubation | 3 | 2022 | 3 | 0.350 |
Why?
|
| Noninvasive Ventilation | 2 | 2022 | 11 | 0.350 |
Why?
|
| Middle Aged | 10 | 2023 | 7981 | 0.340 |
Why?
|
| Male | 11 | 2023 | 12659 | 0.290 |
Why?
|
| Hospital Mortality | 2 | 2021 | 130 | 0.290 |
Why?
|
| Female | 11 | 2023 | 13142 | 0.280 |
Why?
|
| Respiratory Therapy | 2 | 2020 | 7 | 0.270 |
Why?
|
| Administration, Inhalation | 2 | 2017 | 37 | 0.260 |
Why?
|
| Adult | 6 | 2023 | 6959 | 0.250 |
Why?
|
| Allied Health Personnel | 2 | 2023 | 7 | 0.230 |
Why?
|
| Health Personnel | 1 | 2005 | 81 | 0.220 |
Why?
|
| Suction | 2 | 2023 | 31 | 0.210 |
Why?
|
| Infection Control | 2 | 2020 | 168 | 0.200 |
Why?
|
| Certification | 1 | 2023 | 24 | 0.190 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 2021 | 4 | 0.180 |
Why?
|
| Interprofessional Relations | 1 | 2021 | 30 | 0.180 |
Why?
|
| Aged | 6 | 2020 | 7660 | 0.170 |
Why?
|
| APACHE | 2 | 2021 | 22 | 0.170 |
Why?
|
| Respiratory Function Tests | 1 | 2020 | 26 | 0.170 |
Why?
|
| Particulate Matter | 1 | 2020 | 16 | 0.160 |
Why?
|
| Critical Care | 1 | 2021 | 97 | 0.160 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 64 | 0.160 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 1037 | 0.160 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 598 | 0.150 |
Why?
|
| Retrospective Studies | 4 | 2023 | 2993 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 79 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 82 | 0.150 |
Why?
|
| Cannula | 3 | 2022 | 8 | 0.130 |
Why?
|
| Pulmonary Ventilation | 1 | 2017 | 7 | 0.130 |
Why?
|
| Patient Education as Topic | 2 | 2016 | 121 | 0.130 |
Why?
|
| Airway Resistance | 1 | 2017 | 4 | 0.130 |
Why?
|
| Humidifiers | 1 | 2017 | 2 | 0.130 |
Why?
|
| Decontamination | 1 | 2017 | 9 | 0.130 |
Why?
|
| Models, Anatomic | 1 | 2017 | 32 | 0.130 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 18 | 0.130 |
Why?
|
| Perception | 1 | 2017 | 66 | 0.130 |
Why?
|
| Dry Powder Inhalers | 1 | 2016 | 3 | 0.130 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2016 | 6 | 0.130 |
Why?
|
| Teaching Materials | 1 | 2016 | 8 | 0.130 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2017 | 11 | 0.130 |
Why?
|
| Vibration | 1 | 2017 | 24 | 0.130 |
Why?
|
| Prospective Studies | 4 | 2023 | 1512 | 0.120 |
Why?
|
| Pilot Projects | 2 | 2016 | 369 | 0.120 |
Why?
|
| Algorithms | 1 | 2017 | 305 | 0.120 |
Why?
|
| Health Literacy | 1 | 2016 | 87 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2021 | 812 | 0.110 |
Why?
|
| Capnography | 1 | 2013 | 8 | 0.100 |
Why?
|
| Pressure | 1 | 2013 | 49 | 0.100 |
Why?
|
| Reference Values | 1 | 2013 | 169 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2017 | 2943 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2023 | 578 | 0.070 |
Why?
|
| Child | 2 | 2023 | 1160 | 0.070 |
Why?
|
| Young Adult | 1 | 2013 | 1657 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2008 | 49 | 0.070 |
Why?
|
| Students, Health Occupations | 1 | 2005 | 3 | 0.060 |
Why?
|
| Respiratory Tract Diseases | 1 | 2005 | 6 | 0.060 |
Why?
|
| School Admission Criteria | 1 | 2005 | 8 | 0.060 |
Why?
|
| Educational Measurement | 1 | 2005 | 53 | 0.060 |
Why?
|
| Tomography | 1 | 2023 | 12 | 0.050 |
Why?
|
| Atrophy | 1 | 2023 | 68 | 0.050 |
Why?
|
| Pneumonia | 1 | 2003 | 61 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2021 | 19 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2021 | 28 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 27 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 26 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2021 | 24 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2023 | 537 | 0.040 |
Why?
|
| Equivalence Trials as Topic | 1 | 2020 | 2 | 0.040 |
Why?
|
| Sarcopenia | 1 | 2021 | 25 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 1 | 2020 | 23 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 442 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 69 | 0.040 |
Why?
|
| Medicare | 1 | 2020 | 108 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 244 | 0.040 |
Why?
|
| Risk Factors | 2 | 2021 | 2020 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 207 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 778 | 0.040 |
Why?
|
| Fear | 1 | 2018 | 45 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2018 | 94 | 0.030 |
Why?
|
| Mobility Limitation | 1 | 2018 | 78 | 0.030 |
Why?
|
| Work of Breathing | 1 | 2017 | 5 | 0.030 |
Why?
|
| Mucus | 1 | 2017 | 6 | 0.030 |
Why?
|
| Biofilms | 1 | 2017 | 12 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 88 | 0.030 |
Why?
|
| Anxiety | 1 | 2018 | 143 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2017 | 126 | 0.030 |
Why?
|
| Inhalation | 1 | 2016 | 5 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2016 | 37 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 227 | 0.030 |
Why?
|
| Learning | 1 | 2016 | 59 | 0.030 |
Why?
|
| United States | 1 | 2020 | 1803 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 1264 | 0.030 |
Why?
|
| Economics, Pharmaceutical | 1 | 2008 | 3 | 0.020 |
Why?
|
| Health Behavior | 1 | 2008 | 140 | 0.020 |
Why?
|
| Hospitalization | 1 | 2008 | 288 | 0.010 |
Why?
|
| Humidity | 1 | 2003 | 1 | 0.010 |
Why?
|